Phase II Trial of Fludarabine Combined With Intravenous Treosulfan and Allogeneic Hematopoietic Stem-cell Transplantation in Patients With Lymphatic Malignancies.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 04 Apr 2018
At a glance
- Drugs Treosulfan (Primary) ; Fludarabine
- Indications Follicular lymphoma; Graft-versus-host disease; Hodgkin's disease; Lymphoma
- Focus Therapeutic Use
- 19 Apr 2016 Planned End Date changed from 1 Mar 2016 to 1 Apr 2018.
- 19 Apr 2016 Planned primary completion date changed from 1 Mar 2016 to 1 Apr 2018.
- 02 Dec 2015 Planned End Date changed from 1 Mar 2014 to 1 Mar 2016, as reported by ClinicalTrials.gov.